BioAmp harnesses a unique chemistry-based approach to deliver results that can direct care of infections in MINUTES instead of DAYS
Enabling patients to feel better sooner
Supporting evidence-based treatment practice
Promoting judicious and appropriate use of antibiotics
BioAmp’s diagnostic pipeline is powered by DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology
HOW IT WORKS
BioAmp will first apply DETECT to direct care of complicated urinary tract infections, delivering results that enable physicians to treat their patients with RIGHT antibiotic the FIRST time.
Together we are working to combat antibiotic resistance through diagnostic innovation
TARA DEBOER, PH.D.
Chief Executive Officer
Leadership, product ideation and development support, & partnership liaison (corporate relations and investment)
ANGEL RESENDEZ, PH.D.
Director of Chemistry - Small Molecule Discovery
Synthetic chemistry – ideation to lead molecule optimization & CRO/CMO management.
ISHA KANE, B.S.
Project Manager & Market Strategist
Support across all aspect of our business, emphasis on customer relationship support & market intelligence gathering